3.2. Genetic Alteration of TIPE2 was Associated with Poor Diseas/Progression-Free Survival (DFS/PFS) of Non-Small Cell Lung Cancer (NSCLC) Patients. This evidence concerns the gene TIPE2 and non-small cell lung carcinoma.